Latest News
Meet Dijuana Lewis, WellPoint's efficiency czar
Indianapolis Star, The | 24 minutes ago
Hoosier leads WellPoint's effort to keep costs in check... (more)
Neoprobe reports positive FDA meeting
American City Business Journals | 25 minutes ago
Neoprobe Corp. announced that it?s on track to file a new drug application sometime this summer based on a positive early meeting with the U.... (more)
Off-label prescriptions lucrative but dangerous
Milwaukee Journal Sentinel | 25 minutes ago
Related Coverage John Fauber reported this story in a joint project of the Journal Sentinel and MedPage Today. ... (more)
Endo hires former Centocor president McHugh as COO
American City Business Journals | 26 minutes ago
Endo Pharmaceuticals named Julie McHugh as chief operating officer of the specialty pharmaceutical company, effective March 15.... (more)
As universities tighten ethics policies, drug firms turn to private physicians
Milwaukee Journal Sentinel | 27 minutes ago
Close $2,400 Annual cost of Lovaza (above) in its FDA approved dose of 4 grams a day, according to Walgreens ... (more)
Man gets out of jail, then he's right back in
San Francisco Chronicle | 33 minutes ago
You must be signed in to add a comment. Sign In | Register... (more)
Unlocking cancer drug mechanism may avoid risk of birth defects
Japan Times, The | 7 hours 1 minute ago
Scientists have uncovered how a drug used in blood cancer medicines leads to short or missing limbs in babies, moving closer to developing treatments without the risk of such birth defects. Thalidomide, the drug known for causing deformed arms and legs in fetuses, binds with the cereblon protein to inhibit its activity, blocking a process essential to limb development, scientists led by Hiroshi Handa of Tokyo Institute of Technology said in research published in the March 12 issue of t...... (more)
Abiomed Repairs Potentially Dangerous Computer Problem in AB5000 Circulatory-Support Devices
Medscape (free registration) | 7 hours 4 minutes ago
The FDA is classifying Abiomed's repairs of some AB5000 circulatory support systems as a class I recall, indicating that the issue could cause serious injury or death [1].... (more)
Brisbane's InterMune a step closer to marketing lung treatment
San Jose Mercury News (Calif.) | 7 hours 5 minutes ago
For a decade, struggling Brisbane-based InterMune has sought to be the first company to sell a U.S.-approved treatment for a little-known lung disease that is stealing the life away from thousands of people like 75-year-old Walter Carlson of Mountain View.... (more)
Eli Hurvitz steps down from Protalix
Globes (Israel) | 7 hours 6 minutes ago
Eli Hurvitz today announced his resignation as chairman of Protalix Biotherapeutics Inc. (AMEX:), following his resignation as chairman of (Nasdaq: ; TASE: ). Protalix appointed director Zeev Bronfeld as interim chairman. ... (more)
Godrej acquires Nigerian beauty business Tura
Financial Express (India), The | 7 hours 6 minutes ago
FMCG major Godrej Consumer Products Ltd (GCPL) has acquired personal care brand Tura from Nigerias Tura Group. This follows GCPLs acquisitions of Rapidol and Kinky businesses in South Africa over the last two years.... (more)
Final Ratiopharm bids expected this month from Teva, Pfizer
Globes (Israel) | 7 hours 6 minutes ago
"Reuters" reports that (Nasdaq: ; TASE: ) and Pfizer Inc. (NYSE: PFE; LSE: PFZ) have submitted bids for Germany's Ratiopharm GmbH that are less than ?3 billion, the minimum amount that the Merckle family is seeking for the pharmaceutical company. ... (more)
Merck sues Teva over cholesterol drug
Globes (Israel) | 7 hours 6 minutes ago
Merck & Co. (NYSE: MRK) last week sued (Nasdaq: ; TASE: ) to prevent it from selling a generic version of the cholesterol drug Vytorin in the US. ... (more)
Humana CEO compensation for 2009 jumps 26 percent | courier-journal.com | The Courier-Journal
Courier-Journal (Louisville, Ky.), The | 7 hours 12 minutes ago
Health insurer Humana Inc. paid CEO Michael B. McCallister 26 percent more last year than in 2008, largely because of a $1.8 million performance-related bonus.... (more)
Week Of March 1, 2010: Company And People Notes: Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More. - Pharmaceutical Technology
PharmTech.com | 7 hours 17 minutes ago
Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.... (more)
203 Stories | 
RSS Feed
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Minimally invasive sports hernia repair may get athletes 'back in the game' faster, study says
Science Blog
Repair of torn knee meniscus at the time of ACL reconstruction is safe and effective for children
Science Blog
'Tommy John' elbow reconstruction 95 percent successful with grown teen pitchers, study says
Science Blog
New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs
Science Blog
Companies in the news
- Allergan Inc.
- AstraZeneca PLC
- BioSante Pharmaceuticals, Inc.
- Bristol Myers Squibb
- Cell Therapeutics
- Chimerix
- Cordis Corporation
- Eli Lilly & Co.
- Human Genome Sciences
- InterMune Inc
- Johnson & Johnson
- Medtronic Inc
- Merck & Co. Inc.
- Pfizer Inc.
- Smith & Nephew